With proprietary technology from Mayo Clinic, our mission is to create novel health predictors from DNA methylation data, to drive:

Clinical Impact - To deploy these predictors in clinical settings, enabling precise patient risk stratification, informed cancer care options, monitoring post-cancer treatment recovery, and preventing secondary cancer formation.

Consumer Empowerment - To deliver these predictors to consumers for personal health tracking and healthy aging optimization.